Zhi‐Meng Lu

1.9k total citations · 1 hit paper
34 papers, 1.4k citations indexed

About

Zhi‐Meng Lu is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Zhi‐Meng Lu has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hepatology, 21 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Zhi‐Meng Lu's work include Hepatitis C virus research (28 papers), Hepatitis B Virus Studies (21 papers) and Liver Disease Diagnosis and Treatment (7 papers). Zhi‐Meng Lu is often cited by papers focused on Hepatitis C virus research (28 papers), Hepatitis B Virus Studies (21 papers) and Liver Disease Diagnosis and Treatment (7 papers). Zhi‐Meng Lu collaborates with scholars based in China, France and Switzerland. Zhi‐Meng Lu's co-authors include Patrick Marcellin, Teerha Piratvisuth, George Lau, Patrizia Farci, Cihan Yurdaydın, Rui Jin, Selım Gürel, Stephanos J. Hadziyannis, Ferruccio Bonino and M. Diago and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Zhi‐Meng Lu

30 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B

2004 847 citations Patrick Marcellin, George Lau et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhi‐Meng Lu China	13	1.3k	1.3k	96	82	44	34	1.4k
Klaus S. Gutfreund Canada	14	712 0.5×	764 0.6×	228 2.4×	98 1.2×	66 1.5×	25	1.1k
M Yoshiba Japan	9	917 0.7×	951 0.7×	91 0.9×	61 0.7×	113 2.6×	20	1.1k
Jerrold J. Lander United States	11	426 0.3×	316 0.2×	77 0.8×	40 0.5×	39 0.9×	13	592
Jong‐Hon Kang Japan	15	308 0.2×	672 0.5×	313 3.3×	10 0.1×	22 0.5×	29	771
J Eisenburg Germany	16	454 0.3×	383 0.3×	55 0.6×	249 3.0×	61 1.4×	37	737
María Sales Gilabert Spain	2	476 0.4×	534 0.4×	189 2.0×	22 0.3×	37 0.8×	5	624
Chi‐Hang Tse Hong Kong	23	2.1k 1.6×	1.8k 1.4×	115 1.2×	37 0.5×	305 6.9×	41	2.3k
V. Carreño Spain	19	864 0.7×	880 0.7×	98 1.0×	54 0.7×	62 1.4×	66	1.1k
Fanny Lebossé France	14	720 0.5×	757 0.6×	164 1.7×	137 1.7×	103 2.3×	37	1.0k
Stefano De Virgilis Italy	5	309 0.2×	318 0.2×	26 0.3×	13 0.2×	30 0.7×	8	398

Countries citing papers authored by Zhi‐Meng Lu

Since Specialization

Citations

This map shows the geographic impact of Zhi‐Meng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi‐Meng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi‐Meng Lu more than expected).

Fields of papers citing papers by Zhi‐Meng Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi‐Meng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi‐Meng Lu. The network helps show where Zhi‐Meng Lu may publish in the future.

Co-authorship network of co-authors of Zhi‐Meng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi‐Meng Lu. A scholar is included among the top collaborators of Zhi‐Meng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi‐Meng Lu. Zhi‐Meng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Zhi‐Meng, et al.. (2023). Single-cell RNA sequencing reveals distinct tumor microenvironment of ground glass nodules and solid nodules in lung adenocarcinoma. Frontiers in Cell and Developmental Biology. 11. 1198338–1198338. 2 indexed citations

Piratvisuth, Teerha, Patrick Marcellin, M. Popescu, et al.. (2011). Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients. Hepatology International. 7(2). 429–436. 85 indexed citations

Li, Xinhua, Yi Lu, Yun Ling, et al.. (2011). Clinical and molecular characterization of Wilson's disease in China: identification of 14 novel mutations. BMC Medical Genetics. 12(1). 6–6. 39 indexed citations

Ling, Yun, Xinhua Li, Yue Han, et al.. (2010). Association of Genetic Variation in Il28B with Hepatitis C Treatment-Induced Viral Clearance in the Chinese Han Population. Antiviral Therapy. 16(2). 141–147. 40 indexed citations

Mao, Hongju, Honglian Zhang, Hua Zhang, et al.. (2009). Clinical evaluation of a colorimetric oligonucleotide chip for genotyping hepatitis C virus. Clinical Biochemistry. 43(1-2). 214–219. 3 indexed citations

Marcellin, Patrick, Ferruccio Bonino, George Lau, et al.. (2009). Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a. Gastroenterology. 136(7). 2169–2179.e4. 225 indexed citations

Zhang, Xinxin, Gang Hou, Qiang Deng, et al.. (2008). Assessment of Specific Antibodies to F Protein in Serum Samples from Chinese Hepatitis C Patients Treated with Interferon plus Ribavarin. Journal of Clinical Microbiology. 46(11). 3746–3751. 20 indexed citations

Kong, Xiao‐Fei, Xinxin Zhang, Qiming Gong, et al.. (2007). MxA Induction May Predict Sustained Virologic Responses of Chronic Hepatitis B Patients with IFN- α Treatment. Journal of Interferon & Cytokine Research. 27(9). 809–818. 21 indexed citations

Mao, Hongju, Zhi‐Meng Lu, Honglian Zhang, et al.. (2007). Colorimetric oligonucleotide array for genotyping of hepatitis C virus based on the 5′ non-coding region. Clinica Chimica Acta. 388(1-2). 22–27. 6 indexed citations

10.

Farci, Patrizia, Patrick Marcellin, Zhi‐Meng Lu, et al.. (2005). On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R)). 17 indexed citations

11.

Cheng, Guoxiang, et al.. (2005). [Establish a transgenic mice model harboring structural genes of hepatitis C virus].. PubMed. 13(7). 501–4.

12.

Xie, Yao, Dao-zhen Xu, Zhi‐Meng Lu, et al.. (2004). [The influence of HCV genotype on the IFN treatment of patients with chronic hepatitis C].. PubMed. 12(2). 72–5. 3 indexed citations

13.

Zhang, Xinxin, Qiming Gong, Shen‐Ying Zhang, et al.. (2003). Evolution of wild type and mutants of the YMDD motif of hepatitis B virus polymerase during lamivudine therapy. Journal of Gastroenterology and Hepatology. 18(12). 1353–1357. 15 indexed citations

14.

Zhang, Xinxin, Qiang Deng, Shen‐Ying Zhang, et al.. (2003). Broadly cross‐reactive mimotope of hypervariable region 1 of hepatitis C virus derived from DNA shuffling and screened by phage display library. Journal of Medical Virology. 71(4). 511–517. 7 indexed citations

15.

Wei, Jun, et al.. (2002). Detection of anti-preS1 antibodies for recovery of hepatitis B patients by immunoassay. World Journal of Gastroenterology. 8(2). 276–276. 16 indexed citations

16.

Cai, Qian, et al.. (2002). Variant analysis and immunogenicity prediction of envelope gene of HCV strains from China. Journal of Medical Virology. 67(4). 490–500. 8 indexed citations

17.

Wei, Jun, Xiaojin Liu, Yuqin Wang, et al.. (2002). Development of the diagnostic immunoassay to detect anti-PreS1(21-47aa) antibody—a marker suggesting the health improvement of hepatitis B patients. Clinica Chimica Acta. 317(1-2). 159–169. 7 indexed citations

18.

Zhang, Xinxin, et al.. (2001). Effect of multiple mutations in the core promoter and pre‐core/core region of hepatitis B virus genome on the response to interferon in e antigen‐positive chronic hepatitis B. Journal of Gastroenterology and Hepatology. 16(4). 393–398. 6 indexed citations

19.

Wei, Jun, Xiaojin Liu, Guangdi Li, et al.. (2001). Expression, Purification and Preliminary Clinical Use of Recombinant HBsAg GST-PreS1(21--47 aa) Fusion Proteins.. PubMed. 33(4). 379–385. 2 indexed citations

20.

Lau, George, William F. Carman, Stephen Locarnini, et al.. (1999). Treatment of chronic hepatitis B virus infection: An Asia–Pacific perspective. Journal of Gastroenterology and Hepatology. 14(1). 3–12. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact